2026-09-22T10:39:05Z https://www.ideals.illinois.edu/oai-pmh

oai:www.ideals.illinois.edu:2142/82534 2023-07-11 col_2142_5131 col_2142_13007 com_2142_5130 com_2142_13006

Roy, Edward J. Patrick, Todd Allen 2015-09-25T20:45:43Z 2015-09-25T20:45:43Z 10000-01-01 1998 1998 This work may offer insights into the application of bispecific ligand conjugates to the treatment of human cancers. Application of this design includes all tumors that express folate receptors, but additional ligands may be used to target other tumor varieties. Made available in DSpace on 2015-09-25T20:45:43Z (GMT). No. of bitstreams: 2 license.txt: 4848 bytes, checksum: 96035ab3f5e1c23cc7138a224ce498bd (MD5) 9904562.pdf: 11778946 bytes, checksum: 066b04a15e7841aec92b2aa660e9f421 (MD5) Previous issue date: 1998 Embargo set by: Seth Robbins for item 83815 Lift date: Forever Reason: Restricted to the U of I community idenfinitely during batch ingest of legacy ETDs Restricted to the U of I community idenfinitely during batch ingest of legacy ETDs U of I Only 319 p. Thesis (Ph.D.)--University of Illinois at Urbana-Champaign, 1998. http://hdl.handle.net/2142/82534 (MiAaPQ)AAI9904562 eng Biology, Molecular Bispecific Ligand Conjugate Immunotherapy of Choroid Plexus Brain Tumors text Neuroscience Neuroscience University of Illinois at Urbana-Champaign Dissertation Ph.D.